Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fusanori Yotsumoto

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Anticancer Research|April 28, 2026
Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian CancerKohei Miyata, Fusanori Yotsumoto
Molecular Cancer Therapeutics|October 15, 2008
Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transitionHiroshi Yagi, Fusanori Yotsumoto, Shingo Miyamoto
Placenta|May 25, 2025
Presepsin in the amniotic fluid is a useful clinical inflammatory biomarker for the prenatal predictive diagnosis of histologic chorioamnionitis: a retrospective preliminary studyMasamitsu Kurakazu, Daichi Urushiyama, Toyofumi Hirakawa, et al.
Cureus|October 22, 2024
A Case of OHVIRA (Obstructed Hemivagina and Ipsilateral Renal Anomaly) Syndrome Diagnosed After Signs of Infection During PregnancyToyofumi Hirakawa, Daichi Urushiyama, Masamitsu Kurakazu, et al.
Cureus|January 15, 2025
Placental Adhesion Subsequent to Uterine Preservation via Resuscitative Endovascular Balloon Occlusion of the Aorta: A Case ReportKoshiro Nagata, Toyofumi Hirakawa, Daisuke Izuchi, et al.
Cureus|April 13, 2026
Type Three Vasa Previa Diagnosed in Late Pregnancy Despite Apparent Placental Migration: A Case ReportSaki Aramaki, Toyofumi Hirakawa, Ayako Sanui, et al.
Anticancer Research|May 6, 2009
Potential for molecularly targeted therapy against epidermal growth factor receptor ligandsShingo Miyamoto, Tatsuya Fukami, Hiroshi Yagi, et al.
Cancer Science|April 25, 2006
Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapyShingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, et al.
Anticancer Research|August 1, 2025
microRNA in Chorioamnionitis: Emerging Biomarkers for Early DiagnosisChihiro Kiyoshima, Daichi Urushiyama, Kenichi Yoshikawa, et al.
Anticancer Research|May 30, 2012
Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancerKohei Miyata, Fusanori Yotsumoto, Sung Ouk Nam, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Anticancer Research|April 28, 2026
Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian CancerKohei Miyata, Fusanori Yotsumoto
Molecular Cancer Therapeutics|October 15, 2008
Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transitionHiroshi Yagi, Fusanori Yotsumoto, Shingo Miyamoto
Placenta|May 25, 2025
Presepsin in the amniotic fluid is a useful clinical inflammatory biomarker for the prenatal predictive diagnosis of histologic chorioamnionitis: a retrospective preliminary studyMasamitsu Kurakazu, Daichi Urushiyama, Toyofumi Hirakawa, et al.
Cureus|October 22, 2024
A Case of OHVIRA (Obstructed Hemivagina and Ipsilateral Renal Anomaly) Syndrome Diagnosed After Signs of Infection During PregnancyToyofumi Hirakawa, Daichi Urushiyama, Masamitsu Kurakazu, et al.
Cureus|January 15, 2025
Placental Adhesion Subsequent to Uterine Preservation via Resuscitative Endovascular Balloon Occlusion of the Aorta: A Case ReportKoshiro Nagata, Toyofumi Hirakawa, Daisuke Izuchi, et al.
Cureus|April 13, 2026
Type Three Vasa Previa Diagnosed in Late Pregnancy Despite Apparent Placental Migration: A Case ReportSaki Aramaki, Toyofumi Hirakawa, Ayako Sanui, et al.
Anticancer Research|May 6, 2009
Potential for molecularly targeted therapy against epidermal growth factor receptor ligandsShingo Miyamoto, Tatsuya Fukami, Hiroshi Yagi, et al.
Cancer Science|April 25, 2006
Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapyShingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, et al.
Anticancer Research|August 1, 2025
microRNA in Chorioamnionitis: Emerging Biomarkers for Early DiagnosisChihiro Kiyoshima, Daichi Urushiyama, Kenichi Yoshikawa, et al.
Anticancer Research|May 30, 2012
Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancerKohei Miyata, Fusanori Yotsumoto, Sung Ouk Nam, et al.
Pageof 8